Semnur Pharmaceuticals, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Semnur Pharmaceuticals, Inc. is a biotechnology research company based in Palo Alto, California. It focuses on developing non-opioid treatments for back pain for use by pain management clinicians and their patients. Its lead program, SP-102 (SEMDEXA), is a novel injectable corticosteroid gel intended for epidural administration to treat moderate to severe chronic radicular pain or sciatica, formulated without preservatives, particulates, solvents, or surfactants.
The firm plans to develop and commercialize products in the United States directly or with partners, and to pursue regional partnerships outside the United States. It targets underserved back pain patients seeking non-opioid options, with a view toward improving safety and efficacy relative to opioid therapies; recent coverage in 2024 notes ongoing development of non-opioid drug products and potential plans related to public market status.

Sign up for free to view info

Company overview Employee directory